276 related articles for article (PubMed ID: 17023100)
21. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
22. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
[TBL] [Abstract][Full Text] [Related]
23. Lower facial contouring with botulinum toxin type A.
Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin A treatment for contouring of the lower leg.
Han KH; Joo YH; Moon SE; Kim KH
J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
[TBL] [Abstract][Full Text] [Related]
25. More than a cosmetic fix. Combined with physical therapy, botulinum toxin type A can help provide relief for chronic muscle pain.
Silberstein N
Rehab Manag; 2007; 20(1):44, 46. PubMed ID: 17310899
[No Abstract] [Full Text] [Related]
26. The effects of botulinum toxin A on muscle histology during distraction osteogenesis.
Olabisi R; Chamberlain CS; Petr S; Steiner S; Consigny D; Best TM; Vanderby R; Schultz E; Noonan KJ
J Orthop Res; 2009 Mar; 27(3):310-7. PubMed ID: 18752291
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
[TBL] [Abstract][Full Text] [Related]
28. Novel cutaneous uses for botulinum toxin type A.
Bansal C; Omlin KJ; Hayes CM; Rohrer TE
J Cosmet Dermatol; 2006 Sep; 5(3):268-72. PubMed ID: 17177750
[TBL] [Abstract][Full Text] [Related]
29. Incidental finding of dysgeusia relieved by injections of botulinum toxin A.
Heman-Ackah S; Pensak MA
Laryngoscope; 2005 May; 115(5):844-5. PubMed ID: 15867651
[TBL] [Abstract][Full Text] [Related]
30. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup.
Giannantoni A; Porena M; Costantini E; Zucchi A; Mearini L; Mearini E
J Urol; 2008 Mar; 179(3):1031-4. PubMed ID: 18206941
[TBL] [Abstract][Full Text] [Related]
31. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
Crowner BE; Racette BA
Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
[TBL] [Abstract][Full Text] [Related]
32. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type A (Dysport) for the treatment of Zenker's diverticulum.
Spinelli P; Ballardini G
Surg Endosc; 2003 Apr; 17(4):660. PubMed ID: 12574934
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
Casserly P; Timon C
J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
[TBL] [Abstract][Full Text] [Related]
35. Treatment of depression with botulinum toxin A: a case series.
Finzi E; Wasserman E
Dermatol Surg; 2006 May; 32(5):645-9; discussion 649-50. PubMed ID: 16706759
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin A in the treatment of adherence syndrome.
Ozkan SB; Kir E; Dayanir V; Dündar SO
Ophthalmic Surg Lasers Imaging; 2003; 34(5):391-5. PubMed ID: 14509463
[TBL] [Abstract][Full Text] [Related]
37. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study.
Gurevich T; Peretz C; Moore O; Weizmann N; Giladi N
Mov Disord; 2007 Apr; 22(6):880-3. PubMed ID: 17290455
[TBL] [Abstract][Full Text] [Related]
38. Persistent abnormal shoulder elevation after accessory nerve injury and differential diagnosis with post-traumatic focal shoulder-elevation dystonia: report of a case and literature review.
Cossu G; Melis M; Melis G; Ferrigno P; Molari A
Mov Disord; 2004 Sep; 19(9):1109-11. PubMed ID: 15372608
[TBL] [Abstract][Full Text] [Related]
39. Use of botulinum toxin type A injection for neuropathic pain after trigeminal nerve injury.
Yoon SH; Merrill RL; Choi JH; Kim ST
Pain Med; 2010 Apr; 11(4):630-2. PubMed ID: 20210871
[TBL] [Abstract][Full Text] [Related]
40. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
